Browsing Øvrige samlinger by Author "Førsund, Eli"

Now showing items 1-3 of 3

  • Fatigue after initiating rivaroxaban for venous thromboembolism 
    Karlsvik, Tina Margrethe; Borgenvik, Thore Langfeldt; Aadalen, Mirjam; Utne, Kristin Kornelia; Førsund, Eli; Jørgensen, Camilla Tøvik; Holst, René; Jelsness-Jørgensen, Lars-Petter; Ghanima, Waleed Khalid (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)
    Background Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ...
  • Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital 
    Jørgensen, Camilla Tøvik; Brækkan, Sigrid Kufaas; Førsund, Eli; Pettersen, Heidi Hassel; Tjønnfjord, Eirik; Ghanima, Waleed; Tavoly, Mazdak (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2024)
    Background There are limited data on the long-term risk of venous thromboembolism (VTE) after high-risk isolated superficial vein thrombosis (iSVT) treated with anticoagulants. Objectives To determine the short- and ...
  • The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description 
    Jørgensen, Camilla Tøvik; Tavoly, Mazdak; Pettersen, Heidi Hassel; Førsund, Eli; Roaldsnes, Christina; Olsen, Magnus Kringstad; Tjønnfjord, Eirik; Gleditsch, Jostein; Galovic, Aleksandra Grdinic; Vikum, Synne Frønæs; Brækkan, Sigrid Kufaas; Ghanima, Waleed (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2022)
    Purpose The incidence of venous thromboembolism (VTE) is expected to increase over the next decades, further increasing its substantial impact on patients and health care resources. Registries have the benefit of reporting ...